- Exchange: Natl India
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Glenmark Pharmaceuticals Ltd
Add to PortfolioGNP:IN
357.95 INR 5.80 1.65%As of 07:05:56 ET on 05/29/2012.
Snapshot for Glenmark Pharmaceuticals Ltd (GNP)
| Open: | 354.65 | Day's Range: | 350.00 - 360.60 | Volume: | 545,677 | Bid: | 357.95 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 352.15 | 52wk Range: | 264.75 - 386.75 | 1-Yr Rtn: | +21.38% | Ask: | 357.00 |
Key Statistics for GNP
| Current P/E Ratio (ttm) | 21.0188 |
|---|---|
| Estimated P/E (03/2013) | 16.5702 |
| Earnings Per Share (INR) (ttm) | 17.0300 |
| Est. EPS (INR) (03/2013) | 21.6020 |
| Est. PEG Ratio | 0.9786 |
| Market Cap (M INR) | 96,851.84 |
| Shares Outstanding (M) | 270.57 |
| Enterprise Value (M INR) (ttm) | 107,025.76 |
| Enterprise Value/EBITDA (ttm) | 12.63 |
| Price/Book (mrq) | 4.0321 |
| Price/Sale (ttm) | 2.4065 |
| Dividend Indicated Gross Yield | 0.5602 |
| Next Earnings Announcement | 07/26/2012 |
More GNP Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for GNP
- Operating
- Investing
- Financing (M/INR)
Company Profile & Key Executives for GNP
Glenmark Pharmaceuticals Ltd., is a pharmaceutical company. The Company develops generic drugs for inflammation, metabolic disorders, and pain.
| Glenn Mario SaldanhaChairman/Managing Director | Rajesh V DesaiChief Financial Officer |
| Sandeep GuptaChief Operating Officer | Marshall J MendonzaVP:Legal/Joint Secretary |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page